post-add

Health Ministry’s 100 Days Program: A Leap Toward Health Innovation and Pandemic Preparedness

The Department of Health Research (DHR), under the Union Health Ministry, has successfully rolled out its ambitious 100 Days Program, marking significant strides in healthcare innovation, pandemic readiness, and the promotion of indigenous medical technologies.

The Department of Health Research (DHR), under the Union Health Ministry, has successfully rolled out its ambitious 100 Days Program, marking significant strides in healthcare innovation, pandemic readiness, and the promotion of indigenous medical technologies. According to a release from the Press Information Bureau (PIB), the initiative is in line with the government's vision of establishing a more robust, resilient, and self-reliant healthcare system by 2047, as part of the Atmanirbhar Bharat mission.

An achievement of the 100 Days of Health Innovation initiative is the launch of the National One Health Mission (NOHM). This mission focuses on addressing health challenges that arise at the intersection of human, animal, and environmental health. By adopting a multi-sectoral approach, NOHM aims to support India's long-term health security, creating a safer and healthier ecosystem for all.

Additionally, the government has made progress in preparing for future pandemics by establishing a National Network of BSL-3 Laboratories. This network consists of over 20 high-containment labs across various ministries, enhancing the nation’s capability to respond quickly to outbreaks of infectious diseases.

As part of efforts to improve pandemic preparedness, a large-scale mock drill titled “Vishanu Yudh Abhyas” was conducted between 27th and 31st August in the Ajmer District of Rajasthan. The mock drill, centered around the H5N1 virus, involved multiple stakeholders and focused on strengthening the detection of emerging infection hotspots, ensuring timely investigations, and implementing control measures to prevent disease spread.

Another noteworthy initiative is the development of affordable, indigenous drugs for rare diseases, such as Muscular Dystrophy and Gaucher’s Disease. This program aims to significantly reduce the cost of treatment, which is often prohibitively expensive for those affected by these conditions.

In addition to these advancements, the government is also working to modernise the healthcare sector through the establishment of a Centre for Evidence-Based Guidelines. This center will focus on standardising medical practices across India, helping to ensure consistency and quality in healthcare delivery. Furthermore, the creation of the Research to Action vertical within the Department of Health Research will help translate research findings into actionable policies and practices more efficiently.

With these initiatives, the government is taking important steps to future-proof India's healthcare system, ensuring the country is better prepared to face future health challenges and provide cost-effective care to its citizens.

Also Read

Subscribe to our newsletter to get updates on our latest news